Suchergebnisse - "Haanen, J"

PubPharm (92)

1

Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes : diagnostic challenges and lessons learned

enthalten in: ESMO open | 2024

von Borgers, J. | van Schijndel, A. | van Thienen, J. | +7

2

Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit

enthalten in: Immuno-oncology technology | 2023

von Johanna, I. | Daudeij, A. | Devina, F. | +11

3

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer : Results of the MIMOSA trial

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Geurts, V. | Voorwerk, L. | Balduzzi, S. | +11

4

"One more chance to survive" : the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a qualitative study and recommendations for future care

enthalten in: Journal of cancer survivorship : research and practice | 2023

von Egeler, M. | Boomstra, E. | Rohaan, M. | +9

5

Exposure-response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Groenland, S. | Janssen, J. | Nijenhuis, C. | +9

6

Extended follow-up from JAVELIN Renal 101 : subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma

enthalten in: ESMO open | 2023

von Haanen, J. | Larkin, J. | Choueiri, T. | +10

7

Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Versluis, J. | Menzies, A. | Sikorska, K. | +20

8

Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma : study protocol for a randomized phase Ib/IIa trial

enthalten in: BMC cancer | 2022

von Borgers, J. | Burgers, F. | Terveer, E. | +12

9

Management of toxicities from immunotherapy : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Haanen, J. | Obeid, M. | Spain, L. | +10

10

Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma : long-term follow-up results from JAVELIN Renal 101

enthalten in: ESMO open | 2022

von Tomita, Y. | Larkin, J. | Venugopal, B. | +10

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]